Autres langues Q-linea AB

Actions

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:31 29/04/2024			Varia. 5j.	Varia. 1 janv.
2,91 ^SEK	-11,68 %		+39,90 %	-21,35 %

13/03	Q-linea AB (publ) présente de solides résultats d'ASTar à l'AMCLI	CI
27/02	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea receives US FDA 510(k) clearance for the ASTar® System	26/04
Q-linea publish the Annual report for 2023	12/04
Q linea : Strong ASTar results presented at AMCLI	13/03
Q-linea AB Presents Strong ASTar Results At AMCLI	13/03
Q-linea participates in tender for rapid AST	05/03
Year-end report 1 January – 31 December 2023	27/02
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Q-linea presents at AMCLI	15/02
Q-linea Presents at AMCLI	15/02
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	09/02
Q-linea creates separate subsidiary for Podler	09/02
Q-linea signs agreement with logistics partner for the American market	08/02
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024	01/02
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	01/02
Q-linea Lands First ASTar Order from Finnish Distributor	31/01
Labema Oy places its first ASTar order	31/01
Q-Linea AB Receives an Order for an ASTar System	31/01
Q-linea to Cut 40 Jobs in Cost Savings Program	30/01
Q-linea initiates cost savings program	30/01

Aucun résultat pour cette recherche